Search company, investor...

Founded Year



Series B - II | Alive

Total Raised


About Novlead

Novlead is a medical device development company that engages in the research and development and production of new medical devices. It builds a diversified molecular technology platform for immediate generation and sustained release of nitric oxide (NO), and provides new solutions for major clinical pain points in the medical fields such as cardiopulmonary, respiratory, and anti-infection. The company was founded in 2018 and is based in Nanjing, China.

Headquarters Location

No. 73, Tanmi Road Building C1-2, Building 16, Tree House

Nanjing, Jiangsu, 211800,





Novlead Frequently Asked Questions (FAQ)

  • When was Novlead founded?

    Novlead was founded in 2018.

  • Where is Novlead's headquarters?

    Novlead's headquarters is located at No. 73, Tanmi Road, Nanjing.

  • What is Novlead's latest funding round?

    Novlead's latest funding round is Series B - II.

  • How much did Novlead raise?

    Novlead raised a total of $18.81M.

  • Who are the investors of Novlead?

    Investors of Novlead include Lilly Asia Ventures, 3E Bioventures, Co-Stone Venture Capital, Jianyuan Tianhua, Jin Yuan Capital and 4 more.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.